Literature DB >> 14519684

RING finger 1 mutations in Parkin produce altered localization of the protein.

Mark R Cookson1, Paul J Lockhart, Chris McLendon, Casey O'Farrell, Michael Schlossmacher, Matthew J Farrer.   

Abstract

The Parkin gene (PRKN) encodes an E3 protein-ubiquitin ligase for which loss of function is associated with autosomal-recessive juvenile (<20 years) and early-onset Parkinsonism (<45 years). Although detailed pathological reports are scarce, brains from patients with homozygous exonic deletions demonstrate neuronal loss in the substantia nigra, albeit without the Lewy body pathology characteristic of idiopathic Parkinson's disease. However, there are rare descriptions of more florid pathology, including Lewy bodies and tau positive astrocytes in individuals with compound heterozygous mutations. In the present study we examined whether PRKN point mutations, leading to amino acid substitutions, may alter the cellular distribution of the protein produced. Wild-type Parkin was homogeneously distributed throughout the cytoplasm with a small amount of protein in the nucleus after transfection into human embryonic kidney cells. Mutant isoforms with A82E, G328E and C431F amino acid substitutions were also normally distributed. However, two mutant isoforms, R256C and R275W, within RING finger 1 of the Parkin protein (238-293 amino acids), produced an unusual distribution of the protein, with large cytoplasmic and nuclear inclusions. We have replicated this observation in primary cultured neurons and demonstrate, by the accumulation/co-localization of cytoskeletal protein vimentin, that the inclusion bodies are aggresomes, a cellular response to misfolded protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519684     DOI: 10.1093/hmg/ddg328

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

Review 1.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.

Authors:  Hsin F Chien; Christan F Rohé; Maria D L Costa; Guido J Breedveld; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2005-11-22       Impact factor: 2.660

Review 4.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

5.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

6.  A recurrent mutation in PARK2 is associated with familial lung cancer.

Authors:  Donghai Xiong; Yian Wang; Elena Kupert; Claire Simpson; Susan M Pinney; Colette R Gaba; Diptasri Mandal; Ann G Schwartz; Ping Yang; Mariza de Andrade; Claudio Pikielny; Jinyoung Byun; Yafang Li; Dwight Stambolian; Margaret R Spitz; Yanhong Liu; Christopher I Amos; Joan E Bailey-Wilson; Marshall Anderson; Ming You
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

Review 7.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

8.  A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Authors:  Mario R Cornejo-Olivas; Luis Torres; Ignacio F Mata; Pilar Mazzetti; Diana Rivas; Carlos Cosentino; Miguel Inca-Martinez; Juan M Cuba; Cyrus P Zabetian; James B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-01-15       Impact factor: 4.891

9.  Parkin-mediated ubiquitination regulates phospholipase C-gamma1.

Authors:  Nodi Dehvari; Anna Sandebring; Amilcar Flores-Morales; Laura Mateos; Yin-Choy Chuan; Matthew S Goldberg; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

Review 10.  The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.

Authors:  Kelly Jean Thomas; Mark R Cookson
Journal:  Int J Biochem Cell Biol       Date:  2009-03-05       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.